BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lewkowicz E, Gursky O. Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis. Biophys Chem 2022;280:106699. [PMID: 34773861 DOI: 10.1016/j.bpc.2021.106699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rosetti B, Marchesan S. Peptide Inhibitors of Insulin Fibrillation: Current and Future Challenges. Int J Mol Sci 2023;24. [PMID: 36674821 DOI: 10.3390/ijms24021306] [Reference Citation Analysis]
2 Loch RA, Wang H, Marín AP, Berger P, Nielsen H, Chroni A, Luo J. Cross Interactions between Apolipoprotein E and Amyloid Proteins in Neurodegenerative Diseases. Computational and Structural Biotechnology Journal 2023. [DOI: 10.1016/j.csbj.2023.01.022] [Reference Citation Analysis]
3 Brender JR, Ramamoorthy A, Gursky O, Bhunia A. Intrinsic disorder and structural biology: Searching where the light isn't. Biophysical Chemistry 2022. [DOI: 10.1016/j.bpc.2022.106912] [Reference Citation Analysis]
4 Chakrabarti P, Chakravarty D. Intrinsically disordered proteins/regions and insight into their biomolecular interactions. Biophysical Chemistry 2022;283:106769. [DOI: 10.1016/j.bpc.2022.106769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Karamanos TK, Kalverda AP, Radford SE. Generating Ensembles of Dynamic Misfolding Proteins. Front Neurosci 2022;16:881534. [DOI: 10.3389/fnins.2022.881534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Absmeier RM, Rottenaicher GJ, Svilenov HL, Kazman P, Buchner J. Antibodies gone bad – the molecular mechanism of light chain amyloidosis. The FEBS Journal 2022. [DOI: 10.1111/febs.16390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]